Efficacy and Safety of Immune Checkpoint Inhibitors for Advanced Malignant Melanoma: A Meta-Analysis on Monotherapy Vs Combination Therapy

Background: Immune checkpoint inhibitors (ICIs) are approved as cancer immunotherapeutic agents for advanced malignant melanoma (MM) in recent years, and nivolumab and ipilimumab are the most widely used ICIs either alone or in combination. However, their efficacy and safety between single and combi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Cancer 2022-01, Vol.13 (10), p.3091-3102
Hauptverfasser:	Pradeep, Jnaneshwari, Win, Thin Thin, Aye, Saint Nway, Sreeramareddy, Chandrashekhar T
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Bias Chi-square test Clinical trials Combination therapy Immunotherapy Lymphocytes Medical prognosis Medical research Melanoma Meta-analysis Research Paper Skin cancer Statistical analysis Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!